Without a vaccine, there's little chance of getting a handle on the global coronavirus. The German pharmaceutical company CureVac is close to a breakthrough.
Researchers say they are surprised at the number of people who have offered to take part, as they usually struggle to find enough guinea pigs. The study will test the success of a COVID-19 vaccine developed by CureVac.
Just over 60% of people in Germany would be willing to get vaccinated against COVID-19, a new survey has found. For researchers, the staunch opponents aren't the problem — it's the growing number of people on the fence.
The world's wealthiest countries are competing for remdesivir, despite assurances that they would work together to develop drugs that treat COVID-19. Pharmaceuticals giant Gilead Sciences is in an enviable position.
Cases and deaths are surging in the United States as authorities debate whether to close schools in the fall. Tokyo has raised its alert level after a recent spike in infections. Follow DW for the latest.
© 2020 Deutsche Welle |
Legal notice |
| Mobile version